Research On Evaluation Of Investment Value Of Listed Companies In Pharmaceutical Industry

Pharmaceutical industry is an important industry related to the national economy and people's livelihood,which is of great significance to the stable development of social economy and the life and health of the people.In recent years,under the influence of urbanization,aging and many other factors,the pharmaceutical industry has developed rapidly and has broad prospects.The national policy support has also brought new opportunities to the pharmaceutical industry,and its investment value has gradually been valued by people.The average annual earnings of Listed Companies in the pharmaceutical industry are far higher than the average level of the market,but there is a large income gap between the stocks of Listed Companies in the industry.Therefore,it is necessary to evaluate the overall investment value of Listed Companies in the pharmaceutical industry,and find out the companies with investment value.Based on the theory of investment value and previous research,this paper analyzes the investment value of Listed Companies in the pharmaceutical industry.Through the overall analysis of China's pharmaceutical industry and listed companies,it is found that the demand of the pharmaceutical market is growing steadily,the pharmaceutical listed companies have good development space and profit space,and provide good investment opportunities for investors;Through factor analysis,162 listed compan ies in the pharmaceutical industry are ranked in the comprehensive score.According to the results of DEA model,the comprehensive ranking is verified.The results of the two analysis methods are compared and analyzed to select companies with investment value in the pharmaceutical industry.The results show that:it is feasible to use factor analysis and DEA to study the investment value of Listed Companies in the pharmaceutical industry,and the DEA effectiveness of Listed Companies in the pharmaceutical industry is consistent with the comprehensive score ranking of factor analysis;The most valuable companies are our company,Hengrui pharmaceutical,Jichuan pharmaceutical and Dezhan health;Different companies have different profitability,operation ability,debt paying ability and sustainable development ability,and their impact on the company's investment value is also different.When the company's operation ability is relatively consistent,it should focus on debt paying ability and sustainable development ability.The research on the investment value of listed companies is of great significance to investors,managers and other stakeholders.The research in this paper is beneficial to the investment decision-making of investors,and also provides useful reference for managers of Listed Companies in the pharmaceutical industry.It can adjust the direction and strategy in time according to the analysis conclusion,and improve the core competence of enterprises.